Because of her testimony, physicians must be notified when a substitution occurs involving a biologic or interchangeable biosimilar. The bill also has a provision which requires the prescribing practitioner the ability to prohibit substitution.
Regan’s testimony made a difference: As of May 21st, North Carolina Governor McCrory signed House Bill 195 into law!